China Seeks Biotech Stardom: Cash Aplenty, Innovation Needed
SAN FRANCISCO – The global recession left the U.S. and much of the rest of the world strapped for cash, with both harsh venture and capital markets taking their toll on the biotech sector. But in China, the economic situation is "really kind of the reverse," noted Greg Scott, founder and president of ChinaBio LLC.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST